Last reviewed · How we verify

NCT06343220

Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research

Completed Last updated 23 December 2025
What this trial tests

trial in Huntington Disease in 131 participants. Completed in 22 December 2025.

Timeline
10 April 2024
Primary endpoint
22 December 2025
22 December 2025

Quick facts

Lead sponsorHuntington Study Group
StatusCompleted
Study typeOBSERVATIONAL
Enrollment131
Start date10 April 2024
Primary completion22 December 2025
Estimated completion22 December 2025
Sites1 location across United States

Conditions studied

Sponsor

Huntington Study Group

Who can join

18 and older, any sex, with Huntington Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Huntington Disease

Currently open trials in the same condition.

Other Huntington Study Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06343220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing